|CompTox Dashboard (EPA)|
|Chemical and physical data|
|Molar mass||298.423 g/mol g·mol−1|
|3D model (JSmol)|
LY-293284 is a research chemical developed by the pharmaceutical company Eli Lilly and used for scientific studies. It acts as a potent and selective 5-HT1A receptor full agonist. It was derived through structural simplification of the ergoline based psychedelic LSD, but is far more selective for 5-HT1A with over 1000x selectivity over other serotonin receptor subtypes and other targets. It has anxiogenic effects in animal studies.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|